Published in Hum Immunol on May 04, 2006
Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest (2007) 1.56
Genomewide scan for linkage reveals evidence of several susceptibility loci for alopecia areata. Am J Hum Genet (2007) 1.55
What causes alopecia areata? Exp Dermatol (2013) 1.14
Genome-wide pooling approach identifies SPATA5 as a new susceptibility locus for alopecia areata. Eur J Hum Genet (2011) 0.92
Nonsegmental vitiligo and autoimmune mechanism. Dermatol Res Pract (2011) 0.89
Exomic sequencing of immune-related genes reveals novel candidate variants associated with alopecia universalis. PLoS One (2013) 0.83
Coherent somatic mutation in autoimmune disease. PLoS One (2014) 0.78
Association between PTPN22 C1858T polymorphism and alopecia areata risk. Exp Ther Med (2015) 0.75
A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet (2010) 8.48
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet (2012) 4.13
Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol (2006) 2.80
Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. N Engl J Med (2010) 2.47
Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol (2009) 2.43
New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol (2006) 2.06
Meta-analysis of genome-wide studies of psoriasis susceptibility reveals linkage to chromosomes 6p21 and 4q28-q31 in Caucasian and Chinese Hans population. J Invest Dermatol (2004) 1.87
Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat Genet (2012) 1.81
Evaluation and treatment of male and female pattern hair loss. J Am Acad Dermatol (2005) 1.80
Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet (2006) 1.74
Hair loss in women with hyperandrogenism: four cases responding to finasteride. J Am Acad Dermatol (2002) 1.62
Keratin K6c mutations cause focal palmoplantar keratoderma. J Invest Dermatol (2009) 1.51
Experience with low-dose methotrexate for the treatment of eczema in the elderly. J Am Acad Dermatol (2003) 1.45
Olive Oil, Sunflower Oil or no Oil for Baby Dry Skin or Massage: A Pilot, Assessor-blinded, Randomized Controlled Trial (the Oil in Baby SkincaRE [OBSeRvE] Study). Acta Derm Venereol (2016) 1.38
Common variants in FOXP1 are associated with generalized vitiligo. Nat Genet (2010) 1.25
Why some women look young for their age. PLoS One (2009) 1.24
The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo. J Clin Invest (2002) 1.15
Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, and TSLP. J Invest Dermatol (2010) 1.14
Coin exposure may cause allergic nickel dermatitis: a review. Contact Dermatitis (2012) 1.11
Genome-wide analysis identifies a quantitative trait locus in the MHC class II region associated with generalized vitiligo age of onset. J Invest Dermatol (2011) 1.08
Interleukin-1: a key inflammatory mediator in psoriasis? Cytokine (2006) 1.06
The distribution of estrogen receptor beta is distinct to that of estrogen receptor alpha and the androgen receptor in human skin and the pilosebaceous unit. J Investig Dermatol Symp Proc (2003) 1.03
CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases. Pigment Cell Res (2005) 1.02
Alopecia areata: evidence-based treatments. Semin Cutan Med Surg (2009) 0.94
Fibroblasts play a regulatory role in the control of pigmentation in reconstructed human skin from skin types I and II. Pigment Cell Res (2002) 0.93
Current patch test results with the European baseline series and extensions to it from the 'European Surveillance System on Contact Allergy' network, 2007-2008. Contact Dermatitis (2012) 0.92
Effect of olive and sunflower seed oil on the adult skin barrier: implications for neonatal skin care. Pediatr Dermatol (2012) 0.89
Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo. Autoimmun Rev (2006) 0.89
Autoantibodies against tyrosine hydroxylase in patients with non-segmental (generalised) vitiligo. Exp Dermatol (2011) 0.89
The European baseline series in 10 European Countries, 2005/2006--results of the European Surveillance System on Contact Allergies (ESSCA). Contact Dermatitis (2009) 0.87
Single-point haplotype scores telomeric to human leukocyte antigen-C give a high susceptibility major histocompatibility complex haplotype for psoriasis in a Caucasian population. J Invest Dermatol (2005) 0.86
Metal allergy and second-generation metal-on-metal arthroplasties. Contact Dermatitis (2011) 0.85
Simplifying the delivery of melanocytes and keratinocytes for the treatment of vitiligo using a chemically defined carrier dressing. J Invest Dermatol (2008) 0.84
Dermatitis on the knee following knee replacement: a minority of cases show contact allergy to chromate, cobalt or nickel but a causal association is unproven. Contact Dermatitis (2006) 0.84
Analysis of allelic variants in the catalase gene in patients with the skin depigmenting disorder vitiligo. Biochem Biophys Res Commun (2006) 0.84
Koebner's phenomenon in vitiligo: European position paper. Pigment Cell Melanoma Res (2011) 0.83
An update on the safety and tolerability of pimecrolimus cream 1%: evidence from clinical trials and post-marketing surveillance. Dermatology (2007) 0.83
HLA-C, CSTA and DS12346 susceptibility alleles confer over 100-fold increased risk of developing psoriasis: evidence of gene interaction. J Hum Genet (2011) 0.82
Infant skin-cleansing product versus water: a pilot randomized, assessor-blinded controlled trial. BMC Pediatr (2011) 0.82
The modulation of aromatase and estrogen receptor alpha in cultured human dermal papilla cells by dexamethasone: a novel mechanism for selective action of estrogen via estrogen receptor beta? J Invest Dermatol (2006) 0.82
A missense mutation in the cadherin interaction site of the desmoglein 4 gene underlies localized autosomal recessive hypotrichosis. J Invest Dermatol (2005) 0.82
Autoantigens in vitiligo identified by the serological selection of a phage-displayed melanocyte cDNA expression library. J Invest Dermatol (2010) 0.82
The effects of nickel and chromium on human keratinocytes: differences in viability, cell associated metal and IL-1alpha release. Toxicol In Vitro (2007) 0.81
Latex allergy: a health care problem of epidemic proportions. Eur J Dermatol (2002) 0.80
Contact allergy to topical medicaments becomes more common with advancing age: an age-stratified study. Contact Dermatitis (2007) 0.80
A comprehensive pathophysiology of dandruff and seborrheic dermatitis - towards a more precise definition of scalp health. Acta Derm Venereol (2013) 0.80
Genome-wide studies of psoriasis susceptibility loci: a review. J Dermatol Sci (2004) 0.80
Randomized, controlled trial evaluating a baby wash product on skin barrier function in healthy, term neonates. J Obstet Gynecol Neonatal Nurs (2013) 0.79
The Effect of an Emollient Containing Urea, Ceramide NP, and Lactate on Skin Barrier Structure and Function in Older People with Dry Skin. Skin Pharmacol Physiol (2016) 0.78
Vitiligo. BMJ (2010) 0.78
Improved emollient use reduces atopic eczema symptoms and is cost neutral in infants: before-and-after evaluation of a multifaceted educational support programme. BMC Dermatol (2013) 0.78
Investigation of four novel male androgenetic alopecia susceptibility loci: no association with female pattern hair loss. Arch Dermatol Res (2013) 0.78
Occupational allergic contact dermatitis to silver and colophonium in a jeweler. Am J Contact Dermat (2002) 0.78
Effect on skin hydration of using baby wipes to clean the napkin area of newborn babies: assessor-blinded randomised controlled equivalence trial. BMC Pediatr (2012) 0.78
Association analysis of the skin barrier gene cystatin A at the PSORS5 locus in psoriatic patients: evidence for interaction between PSORS1 and PSORS5. Eur J Hum Genet (2008) 0.78
Patch testing is a useful investigation in children with eczema. Contact Dermatitis (2011) 0.78
Predisposition to sensitive skin and atopic eczema. Community Pract (2005) 0.78
Sensory ganglionopathy with livedoid vasculopathy controlled by immunotherapy. Muscle Nerve (2014) 0.77
Investigation of six novel susceptibility loci for male androgenetic alopecia in women with female pattern hair loss. J Dermatol Sci (2013) 0.77
10 years' experience of patch testing with a shoe series in 230 patients: which allergens are important? Contact Dermatitis (2005) 0.77
Identification of known and novel genes whose expression is regulated by endogenous retinoic acid during early embryonic development of the mouse. Mech Dev (2002) 0.77
Contact sensitivity to preservatives in the UK, 2004-2005: results of multicentre study. Contact Dermatitis (2007) 0.77
Congenital stable symmetrical type vitiligo in a patient whose mother developed vitiligo during pregnancy. Eur J Dermatol (2008) 0.77
CLN6 p.I154del mutation causing late infantile neuronal ceroid lipofuscinosis in a large consanguineous Moroccan family. Indian J Pediatr (2012) 0.77
An insertion/deletion polymorphism in the gene encoding angiotensin converting enzyme is not associated with generalised vitiligo in an English population. Arch Dermatol Res (2005) 0.77
Severe pruritus in a patient with urticaria pigmentosa treated with topical 5% urea and 3% polidocanol cream. J Dermatolog Treat (2003) 0.76
Persistent post-occupational dermatitis: report of five cases. Acta Derm Venereol (2006) 0.76
Selected variants of the steroid-5-alpha-reductase isoforms SRD5A1 and SRD5A2 and the sex steroid hormone receptors ESR1, ESR2 and PGR: no association with female pattern hair loss identified. Exp Dermatol (2012) 0.76
Vitiligo treated with topical corticosteroids: children with head and neck involvement respond well. J Am Acad Dermatol (2002) 0.76
Selected variants of the melanocortin 4 receptor gene (MC4R) do not confer susceptibility to female pattern hair loss. Arch Dermatol Res (2012) 0.76
Mapping of melanin-concentrating hormone receptor 1 B cell epitopes predicts two major binding sites for vitiligo patient autoantibodies. Exp Dermatol (2009) 0.76
Vitiligo: what general physicians need to know. Clin Med (2009) 0.76
Age- and sex-related variations in allergic contact dermatitis to common allergens. Contact Dermatitis (2009) 0.76
Comparing the Effect of a Twice-weekly Tacrolimus and Betamethasone Valerate Dose on the Subclinical Epidermal Barrier Defect in Atopic Dermatitis. Acta Derm Venereol (2015) 0.76
Nickel-plated steel coins: the risk to the nickel-allergic public needs wider consideration. Contact Dermatitis (2013) 0.75
Autoantibodies in vitiligo patients recognize multiple domains of the melanin-concentrating hormone receptor. J Invest Dermatol (2003) 0.75
Uveal and cutaneous involvement in paraneoplastic melanocytic proliferation. Arch Ophthalmol (2003) 0.75
Allergic contact dermatitis from aluminium in deodorants. Contact Dermatitis (2010) 0.75
The 3'-UTR AACCins5874 in the stratum corneum chymotryptic enzyme gene (SCCE/KLK7), associated with atopic dermatitis; causes an increased mRNA expression without altering its stability. J Dermatol Sci (2010) 0.75
Allergy risk from Royal Mint's new nickel plated steel coins should be publicly assessed. BMJ (2012) 0.75
The importance of propolis in patch testing--a multicentre survey. Contact Dermatitis (2009) 0.75
Concomitant contact allergy to methylchloroisothiazolinone/methylisothiazolinone and formaldehyde-releasing preservatives. Contact Dermatitis (2010) 0.75
Methicillin-resistant Staphylococcus aureus in skin disease affects mainly elderly patients with eczema and leg ulcers who have associated chronic disease. Acta Derm Venereol (2008) 0.75
Function-blocking autoantibodies to the melanin-concentrating hormone receptor in vitiligo patients. Lab Invest (2006) 0.75
Update on contact dermatitis 2007: Medical pearls from the annual meeting of the British Contact Dermatitis Society at the annual meeting of the British Association of Dermatologists. J Dermatol Sci (2008) 0.75